Sanofi India Limited (SANOFI.BO)

INR 5965.35

(0.56%)

Total Liabilities Summary of Sanofi India Limited

Sanofi India Limited's latest annual total liabilities in 2023 was 6.99 Billion INR , down -12.1% from previous year.
Sanofi India Limited's latest quarterly total liabilities in 2024 Q2 was 6.75 Billion INR , down 0.0% from previous quarter.
Sanofi India Limited reported annual total liabilities of 7.95 Billion INR in 2022, down -4.73% from previous year.
Sanofi India Limited reported annual total liabilities of 8.35 Billion INR in 2021, up 4.49% from previous year.
Sanofi India Limited reported quarterly total liabilities of - INR for 2023 Q3, down -100.0% from previous quarter.
Sanofi India Limited reported quarterly total liabilities of 6.99 Billion INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Sanofi India Limited (2023 - 2004)

Historical Annual Total Liabilities of Sanofi India Limited (2023 - 2004)

Year	Total Liabilities	Total Liabilities Growth
2023	6.99 Billion INR	-12.1%
2022	7.95 Billion INR	-4.73%
2021	8.35 Billion INR	4.49%
2020	7.99 Billion INR	-0.32%
2019	8.02 Billion INR	4.89%
2018	7.64 Billion INR	1.78%
2017	7.51 Billion INR	14.14%
2016	6.58 Billion INR	0.81%
2015	6.52 Billion INR	-11.98%
2014	7.41 Billion INR	39.52%
2013	5.31 Billion INR	24.45%
2012	4.27 Billion INR	10.69%
2011	3.85 Billion INR	-2.12%
2010	3.94 Billion INR	44.13%
2009	2.73 Billion INR	15.8%
2008	2.36 Billion INR	12.53%
2007	2.09 Billion INR	-16.04%
2006	2.5 Billion INR	46.23%
2005	1.7 Billion INR	14.3%
2004	1.49 Billion INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	6.75 Billion INR	0.0%
2023 Q3	- INR	-100.0%
2023 Q4	6.99 Billion INR	0.0%
2023 Q1	- INR	-100.0%
2023 FY	6.99 Billion INR	-12.1%
2023 Q2	7.73 Billion INR	0.0%
2022 Q1	- INR	-100.0%
2022 Q2	7.21 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 FY	7.95 Billion INR	-4.73%
2022 Q4	7.95 Billion INR	0.0%
2021 Q4	8.35 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2021 FY	8.35 Billion INR	4.49%
2021 Q3	- INR	-100.0%
2021 Q2	8.84 Billion INR	0.0%
2020 Q4	7.99 Billion INR	0.0%
2020 FY	7.99 Billion INR	-0.32%
2020 Q2	8.19 Billion INR	0.0%
2019 FY	8.02 Billion INR	4.89%
2019 Q4	8.02 Billion INR	0.0%
2019 Q2	7.6 Billion INR	0.0%
2018 Q4	7.64 Billion INR	0.0%
2018 Q2	7.66 Billion INR	0.0%
2018 FY	7.64 Billion INR	1.78%
2017 FY	7.51 Billion INR	14.14%
2017 Q2	7.18 Billion INR	0.0%
2017 Q4	7.51 Billion INR	0.0%
2016 Q4	6.58 Billion INR	0.0%
2016 FY	6.58 Billion INR	0.81%
2016 Q2	6.88 Billion INR	0.0%
2015 Q2	6.59 Billion INR	0.0%
2015 FY	6.52 Billion INR	-11.98%
2015 Q4	6.52 Billion INR	0.0%
2014 Q4	7.41 Billion INR	0.0%
2014 Q2	4.4 Billion INR	0.0%
2014 FY	7.41 Billion INR	39.52%
2013 Q2	3.81 Billion INR	0.0%
2013 FY	5.31 Billion INR	24.45%
2013 Q4	5.31 Billion INR	0.0%
2012 Q4	4.27 Billion INR	0.0%
2012 FY	4.27 Billion INR	10.69%
2012 Q2	3.2 Billion INR	0.0%
2011 FY	3.85 Billion INR	-2.12%
2011 Q4	3.85 Billion INR	0.0%
2010 FY	3.94 Billion INR	44.13%
2009 FY	2.73 Billion INR	15.8%
2008 FY	2.36 Billion INR	12.53%
2007 FY	2.09 Billion INR	-16.04%
2006 FY	2.5 Billion INR	46.23%
2005 FY	1.7 Billion INR	14.3%
2004 FY	1.49 Billion INR	0.0%

Peer Total Liabilities Comparison of Sanofi India Limited

Name	Total Liabilities	Total Liabilities Difference
Abbott India Limited	14.94 Billion INR	53.191%
Cipla Limited	59.15 Billion INR	88.173%
Gland Pharma Limited	19.37 Billion INR	63.89%
GlaxoSmithKline Pharmaceuticals Limited	17.96 Billion INR	61.049%
Kopran Limited	2.52 Billion INR	-177.618%
Marksans Pharma Limited	5.95 Billion INR	-17.571%
NGL Fine-Chem Limited	929.03 Million INR	-653.036%
Pfizer Limited	6.33 Billion INR	-10.479%
SMS Pharmaceuticals Limited	4.97 Billion INR	-40.549%